Jun 28, 2024 · ESTEVE ACQUIRES HRA PHARMA RARE DISEASES. This expands ESTEVE's portfolio of medications for rare and severe diseases with three products to treat Cushing's …

In the 90 years since our founding, ESTEVE has become a leading healthcare company in Spain, and now an international pharmaceutical innovator and partner with a purposeful expansion …

ESTEVE has an ambitious vision to become an international biopharmaceutical leader in specialty therapeutics. In our home country of Spain, neuroscience has been an area of focus for us. …

Esteve Química, S.A. c/Caracas, 17-19 08030 Barcelona Spain Industrial Sites Production Plant Celrà. Esteve Química, S.A. Carrer Ter nº 94 17460 Celrà - Girona Spain Production Plant …

ESTEVE by the numbers (2023) €710 M net revenues . 8 million patients impact of our products and activities + 2,000 worldwide employees +90 years of expertise. 110 brands in our portfolio …

Apr 25, 2024 · All news related to Esteve, the company, its research and its products and services.

ESTEVE is implementing various programs that are currently in diverse stages of research and development.

Extensive catalogue of own products in areas of specialized medicine, as well as over-the-counter products with leading brands.

Jul 3, 2023 · As of mid-February, healthcare professionals and patients now have a new treatment to counteract OFF-episode symptoms in Parkinson's disease. After having obtained pricing …

Mar 5, 2021 · Esteve Pharmaceuticals (ESTEVE), an international specialty pharmaceutical company devoted to the development and commercialization of innovative products, today …